Ghost Tree Capital, LLC Madrigal Pharmaceuticals, Inc. Transaction History

Ghost Tree Capital, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$171.37 - $283.23 $1.46 Million - $2.41 Million	-8,500 Reduced 56.67%	6,500 $1.74 Million
Q4 2023 Feb 14, 2024	SELL	$120.4 - $237.13 $5.12 Million - $10.1 Million	-42,500 Reduced 73.91%	15,000 $3.47 Million
Q3 2023 Nov 14, 2023	BUY	$146.04 - $225.78 $365,100 - $564,450	2,500 Added 4.55%	57,500 $8.4 Million
Q2 2023 Aug 14, 2023	BUY	$203.88 - $312.0 $5.1 Million - $7.8 Million	25,000 Added 83.33%	55,000 $12.7 Million
Q1 2023 May 15, 2023	BUY	$231.06 - $307.08 $2.31 Million - $3.07 Million	10,000 Added 50.0%	30,000 $7.27 Million
Q4 2022 Feb 14, 2023	SELL	$58.39 - $296.54 $291,950 - $1.48 Million	-5,000 Reduced 20.0%	20,000 $5.81 Million
Q3 2022 Nov 14, 2022	BUY	$60.57 - $79.51 $1.51 Million - $1.99 Million	25,000 New	25,000 $1.63 Million
Q1 2019 May 15, 2019	SELL	$103.48 - $143.84 $93,132 - $129,456	-900 Closed	0 $0
Q4 2018 Apr 09, 2020	BUY	$94.77 - $215.54 $85,293 - $193,986	900 New	900 $101,000
Q4 2018 Feb 14, 2019	SELL	$94.77 - $215.54 $1.35 Million - $3.06 Million	-14,200 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$207.3 - $300.31 $1.93 Million - $2.79 Million	-9,300 Reduced 39.57%	14,200 $3.04 Million
Q2 2018 Aug 14, 2018	BUY	$101.55 - $313.9 $2.39 Million - $7.38 Million	23,500 New	23,500 $6.57 Million

297

21.9M

757K

370K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $3.72B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.